Lopez-Pastorini et al. found that in a large study of 1349 patients with lung cancer (mean age <65 years), a preoperative CRP >40 mg/L was an independent significant indicator for inferior survival within 30 days after surgery [22]. This evidence concerns the gene CRP and lung carcinoma.